Allianz Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
AIM
SUT
Allianz Asset Management's CELL Position: Q3 2021 in Review
Allianz Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2021, closing a stake of 362,625 shares — an estimated $16.2M sold.
Allianz Asset Management first reported a position in CELL in Q3 2020 and held it in 4 quarters. The position peaked at $16.2M in Q2 2021. 137 funds tracked by Wall St. Rank hold CELL as of Q3 2021.
- Allianz Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
- Allianz Asset Management sold 362,625 PhenomeX Inc. Common Stock shares in Q3 2021, an estimated $16.2M.
- Allianz Asset Management first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 4 quarters.
- Allianz Asset Management's PhenomeX Inc. Common Stock position peaked at $16.2M in Q2 2021.
- 137 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2021.
Based on Allianz Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.